new biotech drug for rheumatoid arthritis called Orencia (oh-REN-see-ah)

February 2006

You'll see a new biotech drug for rheumatoid arthritis called Orencia (oh-REN-see-ah).

Orencia (abatacept) is an immune modulator. It inhibits T-cell activation...but it works "upstream" from where TNF blockers work.

This means that Orencia reduces the production of tumor necrosis factor plus other immune modulators. But it's not known if this mechanism improves efficacy.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote